What is Roth Capital's Forecast for MGRM FY2029 Earnings?

Monogram Orthopaedics, Inc. (NASDAQ:MGRM - Free Report) - Analysts at Roth Capital lowered their FY2029 earnings per share estimates for Monogram Orthopaedics in a note issued to investors on Wednesday, April 16th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings per share of $0.35 for the year, down from their previous forecast of $0.41. The consensus estimate for Monogram Orthopaedics' current full-year earnings is ($0.49) per share.

Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report) last posted its quarterly earnings results on Wednesday, March 12th. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.03.

Separately, Roth Mkm increased their target price on shares of Monogram Orthopaedics from $4.00 to $5.40 and gave the company a "buy" rating in a report on Tuesday, March 18th.

Monogram Orthopaedics Trading Down 0.4 %

Shares of NASDAQ:MGRM traded down $0.01 on Thursday, reaching $2.64. 62,387 shares of the company were exchanged, compared to its average volume of 249,104. The company has a 50-day moving average of $2.61 and a 200-day moving average of $2.50. The firm has a market cap of $93.16 million, a price-to-earnings ratio of -5.60 and a beta of 0.77. Monogram Orthopaedics has a 1-year low of $1.82 and a 1-year high of $4.21.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in MGRM. Jane Street Group LLC acquired a new position in Monogram Orthopaedics during the fourth quarter worth about $25,000. Wells Fargo & Company MN raised its position in shares of Monogram Orthopaedics by 286.6% during the 4th quarter. Wells Fargo & Company MN now owns 11,597 shares of the company's stock worth $27,000 after purchasing an additional 8,597 shares during the last quarter. Barclays PLC purchased a new stake in Monogram Orthopaedics in the 3rd quarter valued at approximately $29,000. Orion Portfolio Solutions LLC purchased a new position in Monogram Orthopaedics during the fourth quarter worth $31,000. Finally, State Street Corp acquired a new position in shares of Monogram Orthopaedics in the third quarter worth $62,000. Institutional investors and hedge funds own 0.45% of the company's stock.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.